Skip to content
10-Q

Quarterly Report

Theravance Biopharma, Inc. TBPH

0001558370-25-011408

← back to feed
Filed
Aug 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 1, 2025 50.36M sh
Shares Diluted Q2 2025 · Jun 30, 2025 50.73M sh
Shares Diluted Q2 2025 · Jun 30, 2025 50.69M sh
Shares Diluted Q2 2025 · Jun 30, 2024 48.75M sh
Shares Diluted Q2 2025 · Jun 30, 2024 48.52M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 $251.11M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$5.44M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $281.93M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $37.8M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $46.35M
Stockholders Equity Q2 2025 · Jun 30, 2025 $224.85M
Stockholders Equity Q2 2025 · Mar 31, 2025 $165.98M
Stockholders Equity Q2 2025 · Dec 31, 2024 $175.55M
Stockholders Equity Q2 2025 · Jun 30, 2024 $193.69M
Stockholders Equity Q2 2025 · Mar 31, 2024 $204.87M
Stockholders Equity Q2 2025 · Dec 31, 2023 $213M
Current Liabilities Q2 2025 · Jun 30, 2025 $54.63M
Current Liabilities Q2 2025 · Dec 31, 2024 $32.09M
Current Assets Q2 2025 · Jun 30, 2025 $366.29M
Current Assets Q2 2025 · Dec 31, 2024 $161.07M
Total Assets Q2 2025 · Jun 30, 2025 $426.04M
Total Assets Q2 2025 · Dec 31, 2024 $354.16M
Eps Diluted Q2 2025 · Jun 30, 2025 $1.08
Eps Diluted Q2 2025 · Jun 30, 2025 $0.81
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.34
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.58
Eps Basic Q2 2025 · Jun 30, 2025 $1.09
Eps Basic Q2 2025 · Jun 30, 2025 $0.83
Eps Basic Q2 2025 · Jun 30, 2024 −$0.34
Eps Basic Q2 2025 · Jun 30, 2024 −$0.58
Sga Expense Q2 2025 · Jun 30, 2025 $18.43M
Sga Expense Q2 2025 · Jun 30, 2025 $36.8M
Sga Expense Q2 2025 · Jun 30, 2024 $17.06M
Sga Expense Q2 2025 · Jun 30, 2024 $33.8M
Rd Expense Q2 2025 · Jun 30, 2025 $10.49M
Rd Expense Q2 2025 · Jun 30, 2025 $21.94M
Rd Expense Q2 2025 · Jun 30, 2024 $9.95M
Rd Expense Q2 2025 · Jun 30, 2024 $18.92M
Net Income Q2 2025 · Jun 30, 2025 $54.84M
Net Income Q2 2025 · Jun 30, 2025 $41.26M
Net Income Q2 2025 · Jun 30, 2024 −$16.53M
Net Income Q2 2025 · Jun 30, 2024 −$28.19M
Operating Income Q2 2025 · Jun 30, 2025 −$2.73M
Operating Income Q2 2025 · Jun 30, 2025 −$17.16M
Operating Income Q2 2025 · Jun 30, 2024 −$15.71M
Operating Income Q2 2025 · Jun 30, 2024 −$26.91M
Revenue Q2 2025 · Jun 30, 2025 $26.2M
Revenue Q2 2025 · Jun 30, 2025 $41.58M
Revenue Q2 2025 · Jun 30, 2024 $14.26M
Revenue Q2 2025 · Jun 30, 2024 $28.76M
Stock Repurchased Q2 2025 · Jun 30, 2024 $445K